Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

2011164 citationsJournal Article

Authors

The current data suggested that metformin may improve chemotherapy outcomes and survival for patients who have NSCLC with diabetes.

Good health and well-being

Published in: Cancer

Volume 117, Issue 22, pp. 5103-5111

Field-Weighted Citation Impact: 5.74